About Vakzine Projekt Management
VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. The company was established in 2002 following an initiative of the German Federal Ministry of Education and Research to promote the German market by funding vaccine development.
Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs from academic research and brought them into clinical phase I and II trials.More about us
News & Press
VPM will take part in the Cruzivax Kick-off Meeting, organized by Helmholtz Centre for Infection Research (HZI) from 26 - 27 June 2019 in Frankfurt. Aim of the Cruzivax project is to develop a vaccine against the Chagas disease which is funded by Horizon 2020.
VPM will be present at the BIO International Convention that will take place from 3rd June to 6th June 2019 in Philadelphia, USA.
VPM will be present at the "15. DVMD-Fachtagung: Brücken bauen zwischen Medizin, Informatik, Biometrie und Epidemiologie" which will take place in Düsseldorf on 05-06 March, 2019.